TI  - Comparison of Different Gemcitabine Formulations Regarding Cost-analysis and Duration of Exposure
AU  - KARAKOÇ, M.D.
SO  - Turk J Oncol 2025;40:175-181.
DO  - 10.5505/tjo.2025.4562